This study aims to validate PASD1 expression as a potential target for colorectal cancer immunotherapy by investigating its expression, immunogenicity of PASD1 peptide in inducing CD4 T cell immune response, cytotoxicity and cytokine expression. This evidence concerns the gene PASD1 and colorectal cancer.